Abstract
The product is a sterile, totally bioresorbable implant, whose principle components are polycaprolactone (PCL) microspheres suspended in a gel carrier of carboxymethyl cellulose. Microspheres have a size range of 25–50 μm, and it should be injected with a 27G needle or a 27G or 25G cannula. It comes in a range of four products, the only difference being the time needed for bulk hydrolysis, 1, 2, 3, or 4 years, allowing for a choice of duration according to the different needs for cosmetic or reconstructive purposes. It may be injected either deep, on the pre-periosteal plane, or superficially, in the hypodermis, as all particulate filler injections should be avoided into the dermis and muscles. The major capacity of collagen stimulation makes it suitable either for volume compensation or for major production of collagen type I, the major component of collagen in normal skin (Nicolau, Plast reconstr Surg 119:2271–2286, 2007).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nicolau PJ. Long lasting and permanent fillers: biomaterial influence over host tissue response. Plast Reconstr Surg. 2007;119(7):2271–86.
Stocks D, Sundaram H, Michaels J, Durrani MJ, Wortzman MS, Nelson DB. Rheological evaluation of the physical properties of hyaluronic acid dermal fillers. J Drugs Dermatol. 2011;10:974–80.
De Melo F, Marijnissen-Hofsté JM. Investigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine. Dermatol Ther. 2012;2(1):13–23.
Pitt CG. Poly (e-caprolactone) and its copolymers. In: Chassin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Dekker; 1990. p. 71–119.
Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 2006;27:1735–40.
Nicolau PJ, Marijnissen-Hofsté JM. Neocollagenesis after injection of a polycaprolactone based dermal filler in a rabbit. Eur J Aesthetic Med Dermatol. 2013;3:19–26.
Goldberg DJ, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable ply-L-lactic acid. Dermatol Surg. 2013;39(6):1–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nicolau, P. (2020). Polycaprolactone for the Face. In: Costa, A. (eds) Minimally Invasive Aesthetic Procedures . Springer, Cham. https://doi.org/10.1007/978-3-319-78265-2_78
Download citation
DOI: https://doi.org/10.1007/978-3-319-78265-2_78
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78264-5
Online ISBN: 978-3-319-78265-2
eBook Packages: MedicineMedicine (R0)